From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Vitamin D: Protective Effect Against Multiple Sclerosis?

High serum 25-hydroxyvitamin D levels are associated with lower risk for MS in whites.

Risk for multiple sclerosis (MS) increases at higher latitudes (i.e., with less sun exposure), and studies have suggested a possible benefit of sun exposure or vitamin D supplementation in lowering risk for MS. In addition, vitamin D prevents MS from developing in animal models. A depository of serum samples was used to retrospectively study the vitamin D–MS relation in a case-control study of 257 patients with definite or probable MS and 514 controls matched by age, sex, and race. Analyses were adjusted for latitude of residence and month of serum collection.

Serum 25-hydroxyvitamin D (25-OHD), a marker of bioavailable vitamin D, was measured at least twice in each patient before a diagnosis of MS was recorded. 25-OHD levels and risk for MS were associated only in white patients. A significant 62% relative reduction in risk was noted for subjects in the highest quintile of 25-OHD concentration (>99 nmol/L) compared with those in the lowest (<63 nmol/L). This risk reduction was even stronger when adolescent serum levels were used: 91% reduction for subjects who had levels ≥100 nmol/L before age 20, compared with those who had levels <100 nmol/L.

Comment: The authors emphasize that these observational data do not support clinical use of vitamin D supplementation to lower risk for MS yet. They do recommend a prospective clinical trial of vitamin D supplementation for lowering MS risk, although such a trial might not be feasible because of the number of subjects and length of follow-up that would be required. Evaluating 25-OHD in blacks will require a larger observational study.

— Thomas L. Schwenk, MD

Published in Journal Watch General Medicine December 19, 2006

Citation(s):

Munger KL et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006 Dec 20; 296:2832-8.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Related Content

Other Perspectives

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2006. Massachusetts Medical Society. All rights reserved.